Five things for pharma marketers to know: Friday, February 8, 2019
J&J to add drug prices to ads; Nearly half of newly approved generics not for sale; FDA takes action against Walgreens for selling tobacco to minors.
News
Publicis shares crash 12% after creative agencies slump
WPP, Interpublic, and Omnicom also saw stocks slide.
Read the February 2019 Digital Edition
The February 2019 digital edition includes MM&M’s second annual Data Issue, plus a look back at the JP Morgan Healthcare conference.
Clarity in DTC TV ad drug pricing
Belle Frank is chief strategy officer, global health practice at VMLY&R.
Marketers discuss how they use AI, marketing tech, and analytics to find participants for clinical research
Marketers answer the question: How can AI, marketing tech, and sophisticated analytics be used to help find participants for clinical research?
Johnson & Johnson to put list prices in TV drug ads
The drugmaker will add list prices to ads for Xarelto by the end of March.
Clearing up the ‘cloudiness’ around brand strategy
Calcium executives chatted about the importance of brand strategy at an MM&M event in New York on Wednesday.
‘We’re in a state of permanent beta’: Soundbites from Evolution of the Agency Universe
Leaders from Razorfish Health, Concentric, and Impactiv BioConsult discussed how they are planning for the future of the agency model.
Five things for pharma marketers to know: Thursday, February 7, 2019
Congress invites drugmakers to testify about prices; CHC’s Bigelow wants pharma marketers to stick up for themselves; Microsoft develops service allowing Azure to connect healthcare professionals.
CHC’s Jon Bigelow: Pharma marketers need to ‘state our value’ to Washington
Coalition for Healthcare Communication executive director Jon Bigelow identified issues to watch in Washington for pharma marketers at an MM&M event on Tuesday.
Want to read more?
Please login or register first to view this content.
